世界の急性虚血性脳卒中用医薬品市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Acute Ischemic Stroke Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5565 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、急性虚血性脳卒中用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（タブレット、カプセル、その他）、用途別市場規模（病院、診断センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・急性虚血性脳卒中用医薬品の市場動向 ・企業の競争状況、市場シェア ・急性虚血性脳卒中用医薬品の種類別市場規模と予測2016-2027（タブレット、カプセル、その他） ・急性虚血性脳卒中用医薬品の用途別市場規模と予測2016-2027（病院、診断センター、その他） ・急性虚血性脳卒中用医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・急性虚血性脳卒中用医薬品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・急性虚血性脳卒中用医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・急性虚血性脳卒中用医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・急性虚血性脳卒中用医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sanofi、Biogen、Bayer、Pfizer、Roche、Boehringer Ingelheim、Daiichi Sankyo、Bristol-Myers Squibb、Johnson＆Johnson、AstraZeneca、ZZ Biotech、NoNO Inc、Athersys、SanBio） ・結論

Acute Ischemic Stroke (CIS), also known as Cerebral Infarction (CI), is due to the occlusion of the Cerebral artery caused by the Infarction of brain tissue, accompanied by damage to neurons, astrocytes, oligodendrocytes, is the modern society leading to death and disability of the most important central nervous system vascular events.

Market Analysis and Insights: Global Acute Ischemic Stroke Drugs Market
The global Acute Ischemic Stroke Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Ischemic Stroke Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Ischemic Stroke Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Ischemic Stroke Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Ischemic Stroke Drugs market.

Global Acute Ischemic Stroke Drugs Scope and Market Size
Acute Ischemic Stroke Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Ischemic Stroke Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tablet
Capsule
Other

Segment by Application
Hospitals
Diagnostic Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sanofi
Biogen
Bayer
Pfizer
Roche
Boehringer Ingelheim
Daiichi Sankyo
Bristol-Myers Squibb
Johnson＆Johnson
AstraZeneca
ZZ Biotech
NoNO Inc
Athersys
SanBio

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Ischemic Stroke Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Other
1.3 Market by Application
1.3.1 Global Acute Ischemic Stroke Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acute Ischemic Stroke Drugs Market Perspective (2016-2027)
2.2 Acute Ischemic Stroke Drugs Growth Trends by Regions
2.2.1 Acute Ischemic Stroke Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Ischemic Stroke Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Acute Ischemic Stroke Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Acute Ischemic Stroke Drugs Industry Dynamic
2.3.1 Acute Ischemic Stroke Drugs Market Trends
2.3.2 Acute Ischemic Stroke Drugs Market Drivers
2.3.3 Acute Ischemic Stroke Drugs Market Challenges
2.3.4 Acute Ischemic Stroke Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acute Ischemic Stroke Drugs Players by Revenue
3.1.1 Global Top Acute Ischemic Stroke Drugs Players by Revenue (2016-2021)
3.1.2 Global Acute Ischemic Stroke Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Acute Ischemic Stroke Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Ischemic Stroke Drugs Revenue
3.4 Global Acute Ischemic Stroke Drugs Market Concentration Ratio
3.4.1 Global Acute Ischemic Stroke Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Ischemic Stroke Drugs Revenue in 2020
3.5 Acute Ischemic Stroke Drugs Key Players Head office and Area Served
3.6 Key Players Acute Ischemic Stroke Drugs Product Solution and Service
3.7 Date of Enter into Acute Ischemic Stroke Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Ischemic Stroke Drugs Breakdown Data by Type
4.1 Global Acute Ischemic Stroke Drugs Historic Market Size by Type (2016-2021)
4.2 Global Acute Ischemic Stroke Drugs Forecasted Market Size by Type (2022-2027)

5 Acute Ischemic Stroke Drugs Breakdown Data by Application
5.1 Global Acute Ischemic Stroke Drugs Historic Market Size by Application (2016-2021)
5.2 Global Acute Ischemic Stroke Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acute Ischemic Stroke Drugs Market Size (2016-2027)
6.2 North America Acute Ischemic Stroke Drugs Market Size by Type
6.2.1 North America Acute Ischemic Stroke Drugs Market Size by Type (2016-2021)
6.2.2 North America Acute Ischemic Stroke Drugs Market Size by Type (2022-2027)
6.2.3 North America Acute Ischemic Stroke Drugs Market Size by Type (2016-2027)
6.3 North America Acute Ischemic Stroke Drugs Market Size by Application
6.3.1 North America Acute Ischemic Stroke Drugs Market Size by Application (2016-2021)
6.3.2 North America Acute Ischemic Stroke Drugs Market Size by Application (2022-2027)
6.3.3 North America Acute Ischemic Stroke Drugs Market Size by Application (2016-2027)
6.4 North America Acute Ischemic Stroke Drugs Market Size by Country
6.4.1 North America Acute Ischemic Stroke Drugs Market Size by Country (2016-2021)
6.4.2 North America Acute Ischemic Stroke Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Acute Ischemic Stroke Drugs Market Size (2016-2027)
7.2 Europe Acute Ischemic Stroke Drugs Market Size by Type
7.2.1 Europe Acute Ischemic Stroke Drugs Market Size by Type (2016-2021)
7.2.2 Europe Acute Ischemic Stroke Drugs Market Size by Type (2022-2027)
7.2.3 Europe Acute Ischemic Stroke Drugs Market Size by Type (2016-2027)
7.3 Europe Acute Ischemic Stroke Drugs Market Size by Application
7.3.1 Europe Acute Ischemic Stroke Drugs Market Size by Application (2016-2021)
7.3.2 Europe Acute Ischemic Stroke Drugs Market Size by Application (2022-2027)
7.3.3 Europe Acute Ischemic Stroke Drugs Market Size by Application (2016-2027)
7.4 Europe Acute Ischemic Stroke Drugs Market Size by Country
7.4.1 Europe Acute Ischemic Stroke Drugs Market Size by Country (2016-2021)
7.4.2 Europe Acute Ischemic Stroke Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acute Ischemic Stroke Drugs Market Size (2016-2027)
8.2 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Type
8.2.1 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Application
8.3.1 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Region
8.4.1 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acute Ischemic Stroke Drugs Market Size (2016-2027)
9.2 Latin America Acute Ischemic Stroke Drugs Market Size by Type
9.2.1 Latin America Acute Ischemic Stroke Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Acute Ischemic Stroke Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Acute Ischemic Stroke Drugs Market Size by Type (2016-2027)
9.3 Latin America Acute Ischemic Stroke Drugs Market Size by Application
9.3.1 Latin America Acute Ischemic Stroke Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Acute Ischemic Stroke Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Acute Ischemic Stroke Drugs Market Size by Application (2016-2027)
9.4 Latin America Acute Ischemic Stroke Drugs Market Size by Country
9.4.1 Latin America Acute Ischemic Stroke Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Acute Ischemic Stroke Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acute Ischemic Stroke Drugs Market Size (2016-2027)
10.2 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Type
10.2.1 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Application
10.3.1 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Country
10.4.1 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Acute Ischemic Stroke Drugs Introduction
11.1.4 Sanofi Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Biogen
11.2.1 Biogen Company Details
11.2.2 Biogen Business Overview
11.2.3 Biogen Acute Ischemic Stroke Drugs Introduction
11.2.4 Biogen Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
11.2.5 Biogen Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Acute Ischemic Stroke Drugs Introduction
11.3.4 Bayer Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
11.3.5 Bayer Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Acute Ischemic Stroke Drugs Introduction
11.4.4 Pfizer Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Acute Ischemic Stroke Drugs Introduction
11.5.4 Roche Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Acute Ischemic Stroke Drugs Introduction
11.6.4 Boehringer Ingelheim Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
11.6.5 Boehringer Ingelheim Recent Development
11.7 Daiichi Sankyo
11.7.1 Daiichi Sankyo Company Details
11.7.2 Daiichi Sankyo Business Overview
11.7.3 Daiichi Sankyo Acute Ischemic Stroke Drugs Introduction
11.7.4 Daiichi Sankyo Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
11.7.5 Daiichi Sankyo Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Acute Ischemic Stroke Drugs Introduction
11.8.4 Bristol-Myers Squibb Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Johnson＆Johnson
11.9.1 Johnson＆Johnson Company Details
11.9.2 Johnson＆Johnson Business Overview
11.9.3 Johnson＆Johnson Acute Ischemic Stroke Drugs Introduction
11.9.4 Johnson＆Johnson Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
11.9.5 Johnson＆Johnson Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Acute Ischemic Stroke Drugs Introduction
11.10.4 AstraZeneca Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
11.10.5 AstraZeneca Recent Development
11.11 ZZ Biotech
11.11.1 ZZ Biotech Company Details
11.11.2 ZZ Biotech Business Overview
11.11.3 ZZ Biotech Acute Ischemic Stroke Drugs Introduction
11.11.4 ZZ Biotech Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
11.11.5 ZZ Biotech Recent Development
11.12 NoNO Inc
11.12.1 NoNO Inc Company Details
11.12.2 NoNO Inc Business Overview
11.12.3 NoNO Inc Acute Ischemic Stroke Drugs Introduction
11.12.4 NoNO Inc Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
11.12.5 NoNO Inc Recent Development
11.13 Athersys
11.13.1 Athersys Company Details
11.13.2 Athersys Business Overview
11.13.3 Athersys Acute Ischemic Stroke Drugs Introduction
11.13.4 Athersys Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
11.13.5 Athersys Recent Development
11.14 SanBio
11.14.1 SanBio Company Details
11.14.2 SanBio Business Overview
11.14.3 SanBio Acute Ischemic Stroke Drugs Introduction
11.14.4 SanBio Revenue in Acute Ischemic Stroke Drugs Business (2016-2021)
11.14.5 SanBio Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acute Ischemic Stroke Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablet
Table 3. Key Players of Capsule
Table 4. Key Players of Other
Table 5. Global Acute Ischemic Stroke Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Acute Ischemic Stroke Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Acute Ischemic Stroke Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Acute Ischemic Stroke Drugs Market Share by Regions (2016-2021)
Table 9. Global Acute Ischemic Stroke Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Acute Ischemic Stroke Drugs Market Share by Regions (2022-2027)
Table 11. Acute Ischemic Stroke Drugs Market Trends
Table 12. Acute Ischemic Stroke Drugs Market Drivers
Table 13. Acute Ischemic Stroke Drugs Market Challenges
Table 14. Acute Ischemic Stroke Drugs Market Restraints
Table 15. Global Acute Ischemic Stroke Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Acute Ischemic Stroke Drugs Market Share by Players (2016-2021)
Table 17. Global Top Acute Ischemic Stroke Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Ischemic Stroke Drugs as of 2020)
Table 18. Ranking of Global Top Acute Ischemic Stroke Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Acute Ischemic Stroke Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Acute Ischemic Stroke Drugs Product Solution and Service
Table 22. Date of Enter into Acute Ischemic Stroke Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Acute Ischemic Stroke Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Acute Ischemic Stroke Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Acute Ischemic Stroke Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Acute Ischemic Stroke Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Acute Ischemic Stroke Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Acute Ischemic Stroke Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Acute Ischemic Stroke Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Acute Ischemic Stroke Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Acute Ischemic Stroke Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Acute Ischemic Stroke Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Acute Ischemic Stroke Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Acute Ischemic Stroke Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Acute Ischemic Stroke Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Acute Ischemic Stroke Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Acute Ischemic Stroke Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Acute Ischemic Stroke Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Acute Ischemic Stroke Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Acute Ischemic Stroke Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Acute Ischemic Stroke Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Acute Ischemic Stroke Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Acute Ischemic Stroke Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Acute Ischemic Stroke Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Acute Ischemic Stroke Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Acute Ischemic Stroke Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Acute Ischemic Stroke Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Acute Ischemic Stroke Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Acute Ischemic Stroke Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Acute Ischemic Stroke Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Sanofi Company Details
Table 63. Sanofi Business Overview
Table 64. Sanofi Acute Ischemic Stroke Drugs Product
Table 65. Sanofi Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 66. Sanofi Recent Development
Table 67. Biogen Company Details
Table 68. Biogen Business Overview
Table 69. Biogen Acute Ischemic Stroke Drugs Product
Table 70. Biogen Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 71. Biogen Recent Development
Table 72. Bayer Company Details
Table 73. Bayer Business Overview
Table 74. Bayer Acute Ischemic Stroke Drugs Product
Table 75. Bayer Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 76. Bayer Recent Development
Table 77. Pfizer Company Details
Table 78. Pfizer Business Overview
Table 79. Pfizer Acute Ischemic Stroke Drugs Product
Table 80. Pfizer Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. Roche Company Details
Table 83. Roche Business Overview
Table 84. Roche Acute Ischemic Stroke Drugs Product
Table 85. Roche Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 86. Roche Recent Development
Table 87. Boehringer Ingelheim Company Details
Table 88. Boehringer Ingelheim Business Overview
Table 89. Boehringer Ingelheim Acute Ischemic Stroke Drugs Product
Table 90. Boehringer Ingelheim Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 91. Boehringer Ingelheim Recent Development
Table 92. Daiichi Sankyo Company Details
Table 93. Daiichi Sankyo Business Overview
Table 94. Daiichi Sankyo Acute Ischemic Stroke Drugs Product
Table 95. Daiichi Sankyo Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 96. Daiichi Sankyo Recent Development
Table 97. Bristol-Myers Squibb Company Details
Table 98. Bristol-Myers Squibb Business Overview
Table 99. Bristol-Myers Squibb Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 100. Bristol-Myers Squibb Recent Development
Table 101. Johnson＆Johnson Company Details
Table 102. Johnson＆Johnson Business Overview
Table 103. Johnson＆Johnson Acute Ischemic Stroke Drugs Product
Table 104. Johnson＆Johnson Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 105. Johnson＆Johnson Recent Development
Table 106. AstraZeneca Company Details
Table 107. AstraZeneca Business Overview
Table 108. AstraZeneca Acute Ischemic Stroke Drugs Product
Table 109. AstraZeneca Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 110. AstraZeneca Recent Development
Table 111. ZZ Biotech Company Details
Table 112. ZZ Biotech Business Overview
Table 113. ZZ Biotech Acute Ischemic Stroke Drugs Product
Table 114. ZZ Biotech Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 115. ZZ Biotech Recent Development
Table 116. NoNO Inc Company Details
Table 117. NoNO Inc Business Overview
Table 118. NoNO Inc Acute Ischemic Stroke Drugs Product
Table 119. NoNO Inc Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 120. NoNO Inc Recent Development
Table 121. Athersys Company Details
Table 122. Athersys Business Overview
Table 123. Athersys Acute Ischemic Stroke Drugs Product
Table 124. Athersys Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 125. Athersys Recent Development
Table 126. SanBio Company Details
Table 127. SanBio Business Overview
Table 128. SanBio Acute Ischemic Stroke Drugs Product
Table 129. SanBio Revenue in Acute Ischemic Stroke Drugs Business (2016-2021) & (US$ Million)
Table 130. SanBio Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Ischemic Stroke Drugs Market Share by Type: 2020 VS 2027
Figure 2. Tablet Features
Figure 3. Capsule Features
Figure 4. Other Features
Figure 5. Global Acute Ischemic Stroke Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Diagnostic Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Acute Ischemic Stroke Drugs Report Years Considered
Figure 10. Global Acute Ischemic Stroke Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Acute Ischemic Stroke Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Acute Ischemic Stroke Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Acute Ischemic Stroke Drugs Market Share by Regions (2022-2027)
Figure 14. Global Acute Ischemic Stroke Drugs Market Share by Players in 2020
Figure 15. Global Top Acute Ischemic Stroke Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Ischemic Stroke Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Acute Ischemic Stroke Drugs Revenue in 2020
Figure 17. Global Acute Ischemic Stroke Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Acute Ischemic Stroke Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Acute Ischemic Stroke Drugs Market Share by Type (2016-2027)
Figure 21. North America Acute Ischemic Stroke Drugs Market Share by Application (2016-2027)
Figure 22. North America Acute Ischemic Stroke Drugs Market Share by Country (2016-2027)
Figure 23. United States Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Acute Ischemic Stroke Drugs Market Share by Type (2016-2027)
Figure 27. Europe Acute Ischemic Stroke Drugs Market Share by Application (2016-2027)
Figure 28. Europe Acute Ischemic Stroke Drugs Market Share by Country (2016-2027)
Figure 29. Germany Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Acute Ischemic Stroke Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Acute Ischemic Stroke Drugs Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Acute Ischemic Stroke Drugs Market Share by Region (2016-2027)
Figure 39. China Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Acute Ischemic Stroke Drugs Market Share by Type (2016-2027)
Figure 47. Latin America Acute Ischemic Stroke Drugs Market Share by Application (2016-2027)
Figure 48. Latin America Acute Ischemic Stroke Drugs Market Share by Country (2016-2027)
Figure 49. Mexico Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Acute Ischemic Stroke Drugs Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Acute Ischemic Stroke Drugs Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Acute Ischemic Stroke Drugs Market Share by Country (2016-2027)
Figure 55. Turkey Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Acute Ischemic Stroke Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Sanofi Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
Figure 59. Biogen Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
Figure 60. Bayer Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
Figure 61. Pfizer Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
Figure 63. Boehringer Ingelheim Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
Figure 64. Daiichi Sankyo Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
Figure 66. Johnson＆Johnson Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
Figure 67. AstraZeneca Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
Figure 68. ZZ Biotech Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
Figure 69. NoNO Inc Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
Figure 70. Athersys Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
Figure 71. SanBio Revenue Growth Rate in Acute Ischemic Stroke Drugs Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---